4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052336
Director acquired 2,528,290 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schroeder Thilo Director | 2020-09-29 | Conversion | +1,768,023 | 1,768,023 | I: show line 1 in the form | ||
| Schroeder Thilo Director | 2020-09-29 | Conversion | +760,267 | 2,528,290 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Schroeder Thilo Director | 2020-09-29 | Conversion · Series C Preferred Stock | −1,768,023 | 0 | I: show line 3 in the form | |||||
| Schroeder Thilo Director | 2020-09-29 | Conversion · Series D Preferred Stock | −760,267 | 0 | I: show line 4 in the form |
Loading xslF345X03/doc4.xml…